BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden

Bactiguard AB19 enrolled

Overview

Primary objective of the study is to establish the incidence of all any catheter related complications in BIP CVC and standard CVC groups in patients requiring CVC. (CVC - Central Venous Catheter; BIP - Bactiguard Infection Protection)

Catheter related complications include CRBSI, CRI, Local CVC infection, need to exchange of CVC due to suspected CRI/CRBSI or thrombosis, stop / slower flow in any CVC lumen, local thrombosis, device malfunctions / technical catheter problems, device related adverse events. (CRBSI - Catheter Related Blood Stream Infection; CRI - Catheter Related Infection)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Vascular Access Complication Catheter-Related Infections Catheter Thrombosis Catheter Blockage Catheter Complications Catheter Site Discomfort Catheter Bacteraemia

Interventions

BIP CVCDEVICE

Central venous access with noble metal coated CVC

Standard CVCDEVICE

Central venous access with standard uncoated CVC

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients admitted to the Access Center at Danderyd who need an elective CVC (surgery, infection, nutrition, medication…) 2. Fully recognize and understand patient information 3. Signed informed consent Exclusion Criteria: 1. If CVC present prior to inclusion in the study and no intention to change the present CVC over guidewire 2. Age \< 18 years 3. Pregnant women 4. Known allergy to gold, silver and palladium 5. Participation in other clinical studies which may interfere with this study as judged by the Investigator

Locations (1)

Danderyd Sjukhus

Stockholm, Sweden